Literature DB >> 11503156

Identification of three novel mutations of the noggin gene in patients with fibrodysplasia ossificans progressiva.

O Sémonin1, K Fontaine, C Daviaud, C Ayuso, G Lucotte.   

Abstract

We report noggin mutations in three Spanish families with fibrodysplasia ossificans progressiva (FOP). The three propositi have typical FOP findings; in the first and third families the parents are unaffected, while in the second family the father is partially affected. DNA of the three propositi and their parents was screened by sequencing for mutations in the noggin gene (NOG). Sequencing indicated a G to C mutation at nucleotide 274 of the NOG gene in the first propositus, encoding for the G92R substitution at the peptide level; this first mutation is de novo, the corresponding change not being observed in parents. In the second propositus, a G to T mutation at nucleotide 271 encodes for the G91C substitution, transmitted in the corresponding family by the partially affected father. In the third propositus, sequencing indicated a G to A mutation at nucleotide 275, encoding for the G92E substitution; this third mutation is de novo. All three mutations, as well as the Delta42 deletion already reported, resulted in the alteration of the portion of the NOG gene at positions 265-282, encoding for the potential N-myristoylation site at residues 89-GGGGGA-94. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11503156     DOI: 10.1002/ajmg.1504

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

Review 1.  Heterotopic ossification: a review.

Authors:  E F McCarthy; M Sundaram
Journal:  Skeletal Radiol       Date:  2005-08-25       Impact factor: 2.199

2.  Fibrodysplasia ossificans progressiva without characteristic skeletal anomalies.

Authors:  Hasan Ulusoy
Journal:  Rheumatol Int       Date:  2010-03-27       Impact factor: 2.631

3.  Ski inhibits TGF-β/phospho-Smad3 signaling and accelerates hypertrophic differentiation in chondrocytes.

Authors:  Kyung-Ok Kim; Erik R Sampson; Robert D Maynard; Regis J O'Keefe; Di Chen; Hicham Drissi; Randy N Rosier; Matthew J Hilton; Michael J Zuscik
Journal:  J Cell Biochem       Date:  2012-06       Impact factor: 4.429

Review 4.  Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP).

Authors:  Frederick S Kaplan; Qi Shen; Vitali Lounev; Petra Seemann; Jay Groppe; Takenobu Katagiri; Robert J Pignolo; Eileen M Shore
Journal:  J Bone Miner Metab       Date:  2008-11-01       Impact factor: 2.626

5.  Genetic predisposition to fracture non-union: a case control study of a preliminary single nucleotide polymorphisms analysis of the BMP pathway.

Authors:  Rozalia Dimitriou; Ian M Carr; Robert M West; Alexander F Markham; Peter V Giannoudis
Journal:  BMC Musculoskelet Disord       Date:  2011-02-10       Impact factor: 2.362

6.  Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance.

Authors:  Julia Zimmer; Sandra C Doelken; Denise Horn; Jay C Groppe; Eileen M Shore; Frederick S Kaplan; Petra Seemann
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

7.  Biological activity of a genetically modified BMP-2 variant with inhibitory activity.

Authors:  Uwe Klammert; Joachim Nickel; Kristian Würzler; Christoph Klingelhöffer; Walter Sebald; Alexander C Kübler; Tobias Reuther
Journal:  Head Face Med       Date:  2009-02-02       Impact factor: 2.151

8.  Sporadic Fibrodysplasia Ossificans Progressiva in an Egyptian Infant with c.617G > A Mutation in ACVR1 Gene: A Case Report and Review of Literature.

Authors:  Mohammad Al-Haggar; Nermin Ahmad; Sohier Yahia; Amany Shams; Bothina Hasaneen; Rasha Hassan Hassan; Yahya Wahba; Nanees Abdel-Badie Salem; Dina Abdel-Hady
Journal:  Case Rep Genet       Date:  2013-01-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.